Published in Int J Oncol on March 01, 1995
Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein. Mol Cell Biol (1999) 0.86
Long-Term Anti-Allodynic Effect of Immediate Pulsed Radiofrequency Modulation through Down-Regulation of Insulin-Like Growth Factor 2 in a Neuropathic Pain Model. Int J Mol Sci (2015) 0.79
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet (1994) 5.49
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 4.91
The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child (1979) 3.16
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med (1999) 2.78
Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia (2009) 2.77
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA (1995) 2.71
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood (1999) 2.10
Comment on antigen-reduced infant formulae. ESPGAN Committee on Nutrition. Acta Paediatr (1993) 2.04
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science (2000) 2.03
Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol (2007) 1.82
Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat Med (1998) 1.79
A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet (1998) 1.78
Immune responses to AAV in a phase I study for Canavan disease. J Gene Med (2006) 1.74
CpG dinucleotides are mutation hot spots in phenylketonuria. Genomics (1989) 1.70
Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis (1997) 1.69
Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from healthy sheep in Spain. J Clin Microbiol (2003) 1.67
Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency. Am J Hum Genet (1989) 1.58
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Protein-metabolism kinetics and energy-substrate utilization in infants fed parenteral solutions with different glucose-fat ratios. Am J Clin Nutr (1991) 1.44
A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation. J Am Acad Dermatol (1990) 1.42
Acetylation of nascent polypeptide chains on rat liver polyribosomes in vivo and in vitro. Biochemistry (1975) 1.41
Lupus cystitis: a possible additive risk factor for emphysematous cystitis in diabetes mellitus: discussion about one case. Lupus (2000) 1.39
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther (1993) 1.38
Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer (1995) 1.37
Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse (1995) 1.34
Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther (2001) 1.34
Association of alcohol consumption with total serum immunoglobulin E levels and allergic sensitization in an adult population-based survey. Clin Exp Allergy (2003) 1.29
Delayed presentation to clinics for sexually transmitted diseases by symptomatic patients. A potential contributor to continuing STD morbidity. Sex Transm Dis (1997) 1.27
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P). Vaccine (2001) 1.26
Neurocytoma of spinal cord. Acta Neuropathol (1994) 1.25
Porokeratosis--a mutant clonal keratosis of the epidermis. I. Histogenesis. Arch Dermatol (1970) 1.24
NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene (1999) 1.21
Weight loss in postmenopausal obesity: no adverse alterations in body composition and protein metabolism. Am J Physiol Endocrinol Metab (2000) 1.20
Concordance of chlamydia trachomatis infections within sexual partnerships. Sex Transm Infect (2007) 1.16
In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther (1998) 1.16
The toxic fraction of gliadin digests in coeliac disease. Isolation by chromatography on Biogel P-10. Clin Chim Acta (1982) 1.15
Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer (1994) 1.15
Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. J Clin Invest (1995) 1.13
The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus. Diabetes (1997) 1.09
Schwannoma of the oculomotor nerves. Report of four cases. J Neurosurg (1982) 1.09
Primary cerebral lymphoma: the "ghost tumor". Case report. J Neurosurg (1984) 1.08
Effects of a flexibility and relaxation programme, walking, and nordic walking on Parkinson's disease. J Aging Res (2011) 1.06
Intratumoral hemorrhage in posterior fossa tumors after ventricular drainage. Report of two cases. J Neurosurg (1981) 1.06
Allelic status of chromosome 1 in neoplasms of the nervous system. Cancer Genet Cytogenet (1995) 1.05
Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer (1994) 1.04
Guthrie cards for detection of point mutations in phenylketonuria. Lancet (1988) 1.04
Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J Virol (1999) 1.04
[Partial deficiency of tetrahydrobiopterin]. Arch Fr Pediatr (1983) 1.02
In vitro pathogenetic studies of coeliac disease. Effects of protein digests on coeliac intestinal biopsy specimens maintained in culture for 48 hours. Scand J Gastroenterol (1975) 1.02
Verrucous lesion in patients with discoid lupus erythematosus. Clinical, histopathological and immunofluorescence studies. Br J Dermatol (1978) 1.02
Endoscopic augmentation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease: multicenter study of the Gatekeeper Reflux Repair System. Endoscopy (2004) 1.02
Long range restriction analysis of the bovine casein genes. Nucleic Acids Res (1990) 1.01
Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms. Blood Cancer J (2011) 1.01
Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect (2001) 1.00
Recommended Dietary Allowances (RDAs), Recommended Dietary Intakes (RDIs), Recommended Nutrient Intakes (RNIs), and Population Reference Intakes (PRIs) are not "recommended intakes". J Pediatr Gastroenterol Nutr (1997) 1.00
Child and adolescent psychotherapy research: developmental issues. J Abnorm Child Psychol (1998) 1.00
Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease. J Inherit Metab Dis (2002) 0.99
Increased PIVKA-II concentrations in patients with cystic fibrosis. J Clin Pathol (1992) 0.99
Growth of hydatid cysts evaluated by CT scanning after presumed cerebral hydatid embolism. Case report. J Neurosurg (1982) 0.98
Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle. J Clin Invest (1995) 0.97
[Early effects of the reintroduction of gluten on the intestinal mucosa in celiac disease in remission]. Arch Fr Pediatr (1969) 0.97
Detection and characterisation of Shiga toxin-producing Escherichia coli other than Escherichia coli O157:H7 in wild ruminants. Vet J (2008) 0.97
Molecular and cytogenetic analysis of chromosome 9 deletions in 75 malignant gliomas. Genes Chromosomes Cancer (1994) 0.97
Pheno-genotypic characterisation of Escherichia coli O157:H7 isolates from domestic and wild ruminants. Vet Microbiol (2009) 0.96
SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology (Berl) (1989) 0.96
High prevalence of storage mite sensitization in a general adult population. Allergy (2004) 0.96
Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone. J Perinatol (2007) 0.95
Kinetics of phenylalanine disappearance after intravenous load in phenylketonuria and its genetic variants. Pediatr Res (1979) 0.95
Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study. Pediatr Res (1997) 0.95
High-resolution analysis of chromosome arm 1p alterations in meningioma. Cancer Genet Cytogenet (2000) 0.94
Influence of flow rate on the kinetics of the intestinal absorption of glucose and lysine in children. Gastroenterology (1974) 0.94
Meningiomas of the posterior fossa. Surg Neurol (1983) 0.94
Alterations of NFIA in chronic malignant myeloid diseases. Leukemia (2008) 0.94
Posterior fossa epidermoid cysts. Acta Neurochir (Wien) (1987) 0.94
Direct measurement of extracellular lactate in the human hippocampus during spontaneous seizures. J Neurochem (1994) 0.94
Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI. Neuropediatrics (2006) 0.94
Comment on the content and composition of lipids in infant formulas. ESPGAN Committee on Nutrition. Acta Paediatr Scand (1992) 0.93
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors. Mol Pharm (2012) 0.93
Chromosomal localization and molecular characterization of 53 cosmid-derived bovine microsatellites. Mamm Genome (1995) 0.93
Presence of Shiga toxin-producing E. coli O157:H7 in a survey of wild artiodactyls. Vet Microbiol (2006) 0.92
Cavernomas of the brain. Neurosurgery (1983) 0.92
[Immuno-histochemical study of the intestinal mucosa in children. I. Malabsorption syndromes]. Arch Fr Pediatr (1973) 0.91
[Congenital absence of pancreatic lipase]. Arch Fr Pediatr (1966) 0.91
Cavernomas of the central nervous system: clinical syndromes, CT scan diagnosis, and prognosis after surgical treatment in 25 cases. Acta Neurochir (Wien) (1987) 0.91
"Small-for-flow" syndrome: shifting the "size" paradigm. Med Hypotheses (2013) 0.90
Air embolism from wounds from a pin-type head-holder as a complication of posterior fossa surgery in the sitting position. Case report. J Neurosurg (1981) 0.90
Viral-based gene transfer to the mammalian CNS for functional genomic studies. Trends Neurosci (2001) 0.90
5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning. Eur J Pharmacol (1988) 0.89
Histochemical localization of intestinal disaccharidases: application to peroral biopsy specimens. Nature (1967) 0.89
Clonal chromosome aberrations in neurinomas. Genes Chromosomes Cancer (1993) 0.89
Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan disease. Brain Res Mol Brain Res (2005) 0.89
[Classification and heterogeneity of hyperphenylalaninemias linked to a phenylalanine hydroxylase deficiency]. Arch Fr Pediatr (1987) 0.89
[Distribution of the genotypes of hepatitis C virus in intravenous drug addicts in Argentina]. Medicina (B Aires) (1999) 0.89
Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes. Blood Cancer J (2011) 0.89
5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. Psychopharmacology (Berl) (1989) 0.88